☆ 4.7 Editorial Material

Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Get Full Text
Add to Collection

Journal

CELLULAR & MOLECULAR IMMUNOLOGY
Volume 18, Issue 4, Pages 1058-1060

Publisher

CHIN SOCIETY IMMUNOLOGY
DOI: 10.1038/s41423-021-00641-8

Keywords

-

Categories

Immunology

Funding

  1. National Special Research Program of China for Important Infectious Diseases [2018ZX10302103, 2017ZX10202102]
  2. Natural Science Foundation of China (NSFC) [82041002]
  3. National Key Research and Development Program of China [2020YFC0841400]
  4. Research and Development Program of Guangdong [2020B111123001]
  5. Important Key Program of NSFC [81730060]
  6. Joint-innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou [201803040002]
  7. National Postdoctoral Program for Innovative Talents and the General Program of China Postdoctoral Science Foundation [BX20190398, 2019M663215]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.